The results have shown that breast cancer cells preferentially express Ki‐67 mRNA isoforms with short 3′UTRs, and the expression of shorter Ki‐67 mRNAs leads to an increase in Ki‐67 mRNA stability and translational efficiency. Here, MKI67 is linked to breast cancer.